The prevention and management of haemolytic disease of the newborn. 1994

M Contreras, and M de Silva
North London Blood Transfusion Centre, UK.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012203 Rh Isoimmunization The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother, causing her to produce IMMUNOGLOBULIN G antibodies, which can cross the placenta and destroy the erythrocytes of Rh+ fetuses. Rh isoimmunization can also be caused by BLOOD TRANSFUSION with mismatched blood. Isoimmunization, Rhesus,Rh Sensitization,Isoimmunization, Rh,Isoimmunizations, Rh,Isoimmunizations, Rhesus,Rh Isoimmunizations,Rh Sensitizations,Rhesus Isoimmunization,Rhesus Isoimmunizations,Sensitization, Rh,Sensitizations, Rh
D015997 Neonatal Screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic. Infant, Newborn, Screening,Newborn Infant Screening,Newborn Screening,Neonatal Screenings,Newborn Infant Screenings,Newborn Screenings,Screening, Neonatal,Screening, Newborn,Screening, Newborn Infant,Screenings, Neonatal,Screenings, Newborn,Screenings, Newborn Infant
D018029 Rho(D) Immune Globulin Immunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells. Anti-D-Immunoglobulin,Immune Globulin, Rh,Rh Immune Globulin,Gamulin Rh,MICRhoGAM,Rho(D) Immune Globulin Intravenous (Human),Rho(D) Immune Human Globulin,RhoGAM,Rhophylac,Anti D Immunoglobulin,Globulin, Rh Immune

Related Publications

M Contreras, and M de Silva
February 1992, Journal of the Indian Medical Association,
M Contreras, and M de Silva
December 1970, British journal of haematology,
M Contreras, and M de Silva
June 1967, Irish journal of medical science,
M Contreras, and M de Silva
October 1952, The Medical journal of Australia,
M Contreras, and M de Silva
June 1953, The New Zealand medical journal,
M Contreras, and M de Silva
December 1982, British journal of haematology,
M Contreras, and M de Silva
July 1954, British medical journal,
M Contreras, and M de Silva
March 2009, Lancet (London, England),
M Contreras, and M de Silva
February 1990, BMJ (Clinical research ed.),
M Contreras, and M de Silva
July 1969, Nursing times,
Copied contents to your clipboard!